# Oxus, Inc. — Hazardous Materials Safety Interpretation **Citation:** 10-0241 **Type / status:** guidance / guidance **Agency:** Pipeline and Hazardous Materials Safety Administration **Effective:** Not stated **Published:** 2010-12-17 10-0241 response to Oxus, Inc. concerning 173.185. ## Document text <<>> U.S. Department of Transportation Pipeline and Hazardous Materials Safety Administration 1200 New Jersey Ave, SE Washington, D.C. 20590 DEC 172010 Mrs. Joan Rolwing Oxus, Inc. 1685 Northfield Dr. Rochester Hills, MI 48309 Ref. No.: 10-0241 Dear Mrs. Rolwing: This responds to your November 5, 2010 letter requesting clarification of the Hazardous Materials Regulations (HMR; 49 CFR Parts 171-180) applicable to lithium battery requirements. You indicate that your company, Oxus, Inc., has purchased the design, process, inventory, and all rights to the Delphi Medical Systems device "Portable Oxygen Concentrator, Model RS00400." In 2008, Delphi Medical Systems requested a letter of interpretation from this Office pertaining to whether this product complied with Special Provision 188 and was not otherwise subject to the HMR (08-0034). Specifically, you ask if PHMSA will reconfirm whether this product is in compliance with the HMR. In your letter, dated 11/5/2010, you indicate the Oxus, Inc. "Portable Oxygen Concentrator, Model RS-00400" and external battery module continues to meet the following criteria: (1) the pressure of the oxygen in the device does not exceed 40.6 psia at 20°C; (2) the cells contain not more than 1.5 grams of lithium equivalent content; (3) the lithium ion batteries contain an aggregate equivalent lithium content of not more than 8g; (4) the device contains no other materials subject to the HMR; and (5) the batteries are fully contained in equipment and packaged in a manner to preclude sparks or the generation of a dangerous quantity of heat. Based on the information above, the Oxus, Inc. portable oxygen concentrator and external battery module meet Special Provision 188. Provided they continue to meet the requirements established by Special Provision 188, you are not otherwise subject to the HMR. I trust this satisfies your inquiry. Please contact us if we can be of further assistance. Sincerely, I~~~~~-~- T. Glenn Foster Chief, Regulatory Review and Reinvention Branch Standards and Rulemaking Division <<>> November 5, 2010 Oxus, Inc. 1685 Northfield Dr. Rochester Hills, MI 48309 NItke~ g 113. 18b -3 111· ) DZ S~ 188 ,LiM/uM ~ #Cries //)-tJ:2~1 Office ofHazardous Materials Standards U.S. DOTIPHMSA (PHH-IO) 1200 New Jersey Avenue, SE East building, 2nd Floor Washington, DC 20590 Attention: Mr. Edward T. Mazzullo, Director Mr. Mazzullo, In July of2008, you issued the attached response to Delphi Medical Systems confirming the non-hazardous status ofthe Delphi Medical Systems Portable Oxygen Concentrator (POC) Model RS-00400. In 2010, Oxus America, (also operating under a DBA ofOxus, Inc.), purchased the design, process, inventory and all rights to the Delphi Medical Systems Portable Oxygen Concentrator. Oxus is preparing for launch and is requesting a confirmation that the Portable Oxygen Concentrator Model RS-00400, now to be marketed by Oxus, Inc. is not subject to the HMR. I can confirm that the Model RS-00400 and the external battery module continue to meet the following criteria: 1) the pressure of the oxygen in the device does not exceed 40.6 psia at 20 deg C; 2) the cells contain not more than 1.5 grams of lithium equivalent content; 3) the lithium ion batteries contain an aggregate equivalent lithium content of not more than 8g; 4) the device contains no other materials subject to the HMR; and 5) the batteries are fully contained in equipment and packaged in a manner to preclude sparks or the generation of a dangerous quantity of heat. Based on Special Provision 188, we are requesting a reconfirmation of the letter of interpretation issued to Delphi Medical to be provided to Oxus, Inc. to assure we are in compliance with the HMR and associated standards prior to shipment. I will contact your office next week to understand ifthere is any additional information you may need to facilitate the request. Thank you in advance, Joan Rolwing Oxus, Inc. 249-410-1194 Attachments: I) Letter of Interpretation to Delphi Medical ## Provenance - Official: Yes - Source: - Source ID: `phmsa` - SHA-256: `6288d0714da3b5bc65a8f3b1b137c87560e0d33ed7d07a6508d059c578531f1d` - Retrieved: 2026-08-20T00:59:31.977Z - Exported: 2026-08-23T10:32:42.299Z - Document slug: `phmsa-interpretation-10-0241` ### Source metadata ```json { "materialSubtype": "interpretation", "interpretationArea": "hazardous_materials", "representation": "full_text_from_official_pdf", "companies": [ "Oxus, Inc." ], "individuals": [ "Mrs. Joan Rolwing" ], "refIds": [ "10-0241" ], "catalogDates": [ "2010-12-17" ], "catalogParts": [ 173 ], "catalogRowCount": 1, "sourceRecordUrls": [ "https://www.phmsa.dot.gov/node/59526" ], "linkedAttachmentUrls": [], "unavailableResponseUrls": [], "duplicateRepresentationUrls": [], "citedSections": [ "173.185", "40.6" ], "catalogPageUrls": [ "https://www.phmsa.dot.gov/regulations/title49/section/173185" ], "pdfUrls": [ "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2010/100241.pdf" ], "representations": [ { "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2010/100241.pdf", "detailUrl": null, "detailHtmlPath": null, "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2010/100241.pdf", "pdfArtifactPath": "data/sources/phmsa-interpretations/10-0241-da707b4104.pdf", "pdfArtifactSha256": "d8b50f453bd68e87209eb3e69b52e2363560d118fc91af0dc6cef1b067aa13c9", "extractedTextPath": "data/sources/phmsa-interpretations/10-0241-da707b4104.v2.txt", "extractedTextSha256": "8fa640485f91518167ba6ff123707dcae196ebf80a07cbed4c33be02fb7dc4b3", "pageCount": 2, "extractionVersion": 2 } ], "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.", "jurisdiction": "US" } ```